Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-97-011272
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
11
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-K405 10-K405 104617
2 EXH 3.1 RESTATED CERTIFICATE OF INCORPORATION EX-3.1 40157
3 EXH 3.2 RESTATED BYLAWS EX-3.2 27767
4 EXH. 10.1 TECHNOLOGY LICENSE AGREEMENT EX-10.1 25224
5 EXH. 10.2 DEVELOPMENT AGREEMENT EX-10.2 55889
6 EXH. 10.3 LICENSE OPTION AGREEMENT EX-10.3 43045
7 EXH. 10.4 SERVICES AGREEMENT EX-10.4 14015
8 EXH. 10.5 AMENDED AND RESTATED 1993 STOCK OP. PLAN EX-10.5 21372
9 EXH. 10.6 EXECUTIVE DEFERRAL PLAN EX-10.6 59040
10 EXH. 10.7 AGREEMENT AND AMENDMENT EX-10.7 21351
11 FINANCIAL DATA SCHEDULE EX-27 2274
  Complete submission text file 0000912057-97-011272.txt   417225
Mailing Address
Business Address 1375 CALIFORNIA AVENUE P O BOX 10051 PALO ALTO CA 94303 4154968203
THERAPEUTIC DISCOVERY CORP (Filer) CIK: 0000899753 (see all company filings)

EIN.: 943173191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 005-45501 | Film No.: 97570045
SIC: 2834 Pharmaceutical Preparations